Euonymus alatus extract ameliorates DSS-induced experimental colitis and attenuates NLRP3 inflammasome-associated pyroptosis in macrophages

Context Euonymus alatus (Thunb.) Siebold has been traditionally used in East Asian medicine for dysentery and inflammatory disorders. However, its effects on intestinal inflammation and barrier injury remain unclear.Objective To evaluate E. alatus extract (EEA) in dextran sulfate sodium (DSS)-induced colitis and examine inflammatory, inflammasome-related, pyroptosis-associated, and epithelial barrier responses.Materials and methods EEA was profiled using ultra-high-performance liquid chromatography–tandem mass spectrometry. Colitis was induced in male C57BL/6 mice (five groups, n = 8/group) using two cycles of 2.0% DSS in drinking water (6 and 5 days of DSS exposure separated by a 7-day DSS-free interval). Cytokine-stimulated Caco-2 epithelial cells and lipopolysaccharide/adenosine triphosphate-stimulated J774A.1 macrophages were also used. Histological and molecular assessments, barrier assays, RNA sequencing, and network pharmacology analyses were performed.Results EEA contained flavonoids and phenolic and reduced weight loss, disease activity, and histological injury; high-dose EEA increased colon length from 6.67 ± 0.18 to 7.58 ± 0.13 cm (p = 0.003 vs. N.C.). EEA decreased MPO- and F4/80-positive infiltration and inflammatory/inflammasome-related transcripts. In Caco-2 cells, EEA improved barrier function and increased ZO-1 and occludin expression. In J774A.1 macrophages, EEA reduced pyroptotic cell death, IL-1β and IL-18 release, ASC oligomerization and specks, cleaved caspase-1, mature IL-1β, and GSDMD-NT. Selected phytochemicals partly reproduced these effects. Transcriptomic and network analyses implicated inflammatory and barrier-related pathways.Discussion and conclusions EEA attenuated DSS-induced experimental colitis and modulated inflammatory, inflammasome-related, epithelial barrier, and pyroptosis-associated responses. Further validation in other experimental models is needed to establish its broader relevance to IBD.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Biology
Published
2026-11-05
DOI
https://doi.org/10.1080/13880209.2026.2757313
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Euonymus alatus extract ameliorates DSS-induced experimental colitis and attenuates NLRP3 inflammasome-associated pyroptosis in macrophages

Doeun Jeon, Ami Lee, Youn‐Hwan Hwang, Hyunil Ha et al.
Pharmaceutical Biology
Inflammatory Bowel Disease
article

Euonymus alatus extract ameliorates DSS-induced experimental colitis and attenuates NLRP3 inflammasome-associated pyroptosis in macrophages

Doeun Jeon, Ami Lee, Youn‐Hwan Hwang, Hyunil Ha, Jin Ah Ryuk, Jihee Choi, Seong Eun Jin, Han Na Kang
article en

Abstract

Context Euonymus alatus (Thunb.) Siebold has been traditionally used in East Asian medicine for dysentery and inflammatory disorders. However, its effects on intestinal inflammation and barrier injury remain unclear.Objective To evaluate E. alatus extract (EEA) in dextran sulfate sodium (DSS)-induced colitis and examine inflammatory, inflammasome-related, pyroptosis-associated, and epithelial barrier responses.Materials and methods EEA was profiled using ultra-high-performance liquid chromatography–tandem mass spectrometry. Colitis was induced in male C57BL/6 mice (five groups, n = 8/group) using two cycles of 2.0% DSS in drinking water (6 and 5 days of DSS exposure separated by a 7-day DSS-free interval). Cytokine-stimulated Caco-2 epithelial cells and lipopolysaccharide/adenosine triphosphate-stimulated J774A.1 macrophages were also used. Histological and molecular assessments, barrier assays, RNA sequencing, and network pharmacology analyses were performed.Results EEA contained flavonoids and phenolic and reduced weight loss, disease activity, and histological injury; high-dose EEA increased colon length from 6.67 ± 0.18 to 7.58 ± 0.13 cm (p = 0.003 vs. N.C.). EEA decreased MPO- and F4/80-positive infiltration and inflammatory/inflammasome-related transcripts. In Caco-2 cells, EEA improved barrier function and increased ZO-1 and occludin expression. In J774A.1 macrophages, EEA reduced pyroptotic cell death, IL-1β and IL-18 release, ASC oligomerization and specks, cleaved caspase-1, mature IL-1β, and GSDMD-NT. Selected phytochemicals partly reproduced these effects. Transcriptomic and network analyses implicated inflammatory and barrier-related pathways.Discussion and conclusions EEA attenuated DSS-induced experimental colitis and modulated inflammatory, inflammasome-related, epithelial barrier, and pyroptosis-associated responses. Further validation in other experimental models is needed to establish its broader relevance to IBD.

Pharmaceutical BiologyVol. 64(1)
Korea Institute of Oriental Medicine (KR), Korea University of Science and Technology (KR)
Openalex Percentile: Top 13%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon